Proton-dependent inhibition of yeast and brain hexokinases by aluminum in ATP preparations
- PMID: 116225
- PMCID: PMC413083
- DOI: 10.1073/pnas.76.10.5080
Proton-dependent inhibition of yeast and brain hexokinases by aluminum in ATP preparations
Abstract
The aluminum present as a contaminant in ATP preparations can cause strong inhibition of yeast hexokinase P-II activity at pH 7.0 or below but has little or no inhibitory effect at a pH of 7.5 or greater. The inhibition is reversed by citrate, 3-phosphoglycerate, malate, phosphate, and catecholamines, all of which have previously been described as activators of hexokinase at low pH. We suggest that these agents activate the enzyme only by virtue of their ability to coordinate with aluminum present in the assay system. The presence of aluminum is also responsible for the "negative cooperativity" observed at low pH with respect to Mg . ATP concentration--i.e., the inhibition by aluminum is uncompetitive at low Mg . ATP concentrations but becomes competitive at high Mg . ATP concentrations. The inhibition is thought to be due to formation of a complex of Al . ATP with the enzyme, with a dissociation constant (Ki) of 0.1 microM. Yeast hexokinase P-I is somewhat less sensitive to A1 than is hexokinase P-II, and yeast glucokinase is not detectably affected. The hexokinase in rat brain (type I) shows a pH-dependent inhibition by Al similar to that observed with the yeast hexokinases, whereas the rat muscle (type II) enzyme is less sensitive, suggesting a possible relationship to aluminum encephalopathy in man.
Similar articles
-
Interaction of metal(III)-adenosine 5'-triphosphate complexes with yeast hexokinase.Biochemistry. 1980 Jul 8;19(14):3131-7. doi: 10.1021/bi00555a003. Biochemistry. 1980. PMID: 6996699
-
Trehalose-6-phosphate, a new regulator of yeast glycolysis that inhibits hexokinases.FEBS Lett. 1993 Aug 23;329(1-2):51-4. doi: 10.1016/0014-5793(93)80191-v. FEBS Lett. 1993. PMID: 8354408
-
Aluminum inhibition of hexokinase activity in vitro: a study in biological availability.J Inorg Biochem. 1994 Jun;54(4):297-304. doi: 10.1016/0162-0134(94)80035-9. J Inorg Biochem. 1994. PMID: 8014638
-
Use of adenine nucleotide derivatives to assess the potential of exo-active-site-directed reagents as species- or isozyme-specific enzyme inactivators. 5. Interactions of adenosine 5'-triphosphate derivatives with rat pyruvate kinases, Escherichia coli thymidine kinase, and yeast and rat hexokinases.J Med Chem. 1982 Apr;25(4):386-92. doi: 10.1021/jm00346a011. J Med Chem. 1982. PMID: 7040662
-
Aluminum interaction with biomolecules: the molecular basis for aluminum toxicity.Am J Kidney Dis. 1985 Nov;6(5):353-7. doi: 10.1016/s0272-6386(85)80093-7. Am J Kidney Dis. 1985. PMID: 3904428 Review. No abstract available.
Cited by
-
Inhibition of H+-transporting ATPase by formation of a tight nucleoside diphosphate-fluoroaluminate complex at the catalytic site.Proc Natl Acad Sci U S A. 1988 Dec;85(23):8958-62. doi: 10.1073/pnas.85.23.8958. Proc Natl Acad Sci U S A. 1988. PMID: 2904148 Free PMC article.
-
Studies of aluminum in rat brain.Biol Trace Elem Res. 1987 Aug;13(1):43-53. doi: 10.1007/BF02796620. Biol Trace Elem Res. 1987. PMID: 24254664
-
Aluminium perturbs oscillatory phosphoinositide-mediated calcium signalling in hormone-stimulated hepatocytes.Biochem J. 1990 Jul 15;269(2):547-50. doi: 10.1042/bj2690547. Biochem J. 1990. PMID: 2167073 Free PMC article.
-
Effects of aluminium on electrical and mechanical properties of frog atrial muscle.Br J Pharmacol. 1991 Feb;102(2):483-91. doi: 10.1111/j.1476-5381.1991.tb12198.x. Br J Pharmacol. 1991. PMID: 2015425 Free PMC article.
-
Would decreased aluminum ingestion reduce the incidence of Alzheimer's disease?CMAJ. 1991 Oct 1;145(7):793-804. CMAJ. 1991. PMID: 1822096 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous